Key facts
- IntelyCare’s last known valuation is $1.1B (Apr 2022).
- It has raised $173.8M across 4 recorded rounds; the latest was Later Stage VC ($97.3M) in Mar 2022.
- Notable investors include First Trust Capital Partners, Eastward Capital Partners, Revelation Partners, Longitude Capital, Kaiser Permanente Ventures — 14 tracked in total.
- IntelyCare has filed 5 Form Ds with the SEC since 2017, most recently Apr 2022 ($97.3M sold to 19 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for IntelyCare
Funding rounds
4 roundsAbout IntelyCare
Developer of an intelligent healthcare workforce management platform designed to assist in hiring nursing and healthcare staff. The company's platform utilizes artificial intelligence to automate scheduling and filling shifts at nursing facilities, as well as to hire professionally qualified care relief staff. It also offers a proprietary system to automatically check the status of nurses and certified nursing assistant state licenses, enabling hospitals and clinics to hire nurses and staff simply and efficiently.
- Sector
- Healthcare
- HQ
- Quincy, MA, United States
- Founded
- 2014
- Employees
- 1,327
- Website
- intelycare.com/
- Ownership
- Privately Held (backing)
IntelyCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IntelyCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IntelyCare in its N-PORT filings yet. We sweep new filings monthly.